PDT Partners, LLC

Position in BHC — Bausch Health Companies Inc.

CIK 1564702 New York, NY

Position in BHC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$206,295

-$63,948 QoQ

Shares Held

41,845

-16.4% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#120

of 220 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PDT Partners, LLC holds $16,723,036 across 8 Drug Manufacturers - Specialty & Generic names. BHC ranks #8 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INDV	Indivior Pharmaceuticals, Inc.	117,378	$4,816,019
2	ANIP	Ani Pharmaceuticals Inc	45,442	$3,761,688
3	PCRX	Pacira BioSciences, Inc.	132,368	$3,358,176
4	KNSA	Kiniksa Pharmaceuticals International, plc	40,567	$2,594,259
5	SUPN	Supernus Pharmaceuticals, Inc.	25,858	$1,202,655
6	ETON	Eton Pharmaceuticals, Inc.	14,891	$539,054
7	BCRX	Biocryst Pharmaceuticals Inc	24,489	$244,890
8	BHC	Bausch Health Companies Inc. This page	41,845	$206,295

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$206,295	41,845	-16.4%	Shares	Sole	2026-08-14
2026-03-31	$270,243	50,045	0.0%	Shares	Sole	2026-05-15
2025-12-31	$347,812	50,045	+19.6%	Shares	Sole	2026-02-17
2025-09-30	$269,900	41,845	0.0%	Shares	Sole	2025-11-17
2025-06-30	$278,687	41,845	-75.9%	Shares	Sole	2025-08-14
2023-03-31	$1,405,827	173,559	+94.5%	Shares	Sole	2023-05-15
2022-12-31	$560,245	89,211	-3.5%	Shares	Sole	2023-02-14
2022-09-30	$637,008	92,454	-66.3%	Shares	Sole	2022-11-14
2022-06-30	$2,292,730	274,250	+372.8%	Shares	Sole	2022-08-15
2022-03-31	$1,325,437	58,006	+289.3%	Shares	Sole	2022-05-16
2020-09-30	$231,546	14,900	-94.1%	Shares	Sole	2020-11-16
2020-06-30	$4,607,598	251,919	-34.4%	Shares	Sole	2020-08-14
2020-03-31	$5,952,790	384,051	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.